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Abstract 
Background: The rapid emergence of new psychoactive substances (NPS) is a challenge for public health authorities and law enforcement. 
The phenomenon is strengthened since the increase of the Internet usage.  Not only used to trade NPS, the Web is an important source of 
information for both potential drug consumers and experienced users. Discussion forums are among these sources of information. They are 
meeting points for different groups of users and include a wide range of trip reports, questions and consumption tips. Since the discussions 
are archived over a long period, they can be used to monitor the interest of consumers for particular substances over time. This research 
aims at understanding the contribution of data extracted from a major online discussion forum within a systematic monitoring process. 
Method: Data were collected from a discussion forum (i.e. Drugs-forum). Within the sections of the forum, the titles, content of discussion, 
number of replies, and the date of the first discussion were crawled and stored in a dedicated database. The intensity of the discussions 
related to 42 substances considered as NPS was measured through an indicator allowing to assess the popularity of substances. Furthermore, 
the appearance of 15 substances on the forum was compared to the date of formal notification to the EU early warning system. 
Results: An evolution of the different classes of substances, as well as an evolution of specific substances within a class were highlighted. 
Some substances were discussed for a long period of time (e.g. Kratom, 25i-NBOMe, MDPV) while others were discussed very briefly 
(e.g. 5-MeO-DPT, NM-2AI). Out of the fifteen substances subjected to a risk assessment from the European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA), nine of them appeared on the forum before or at the same time as their first date of notification to the EU 
early warning system.  
Conclusion: In line with previous research on doping products, this article shows the potential of the monitoring of online forums in the 
context of psychoactive substances. Besides, the system designed to collect the data is flexible and can be systematically updated to fuel a 
monitoring process. It informs not only on the presence/absence of a substance in discussions between consumers, but also on its evolution 
over time. Such results could benefit academic research and organizations studying the NPS phenomenon. Precisely, it could complement 
existing early warning systems and benefit law enforcement agencies and policy makers. 
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1. Introduction 
New psychoactive substances (NPS) constitute a challenge for both public health and law enforcement authorities. There is a 
large number of substances that are monitored by international organisations such as the European Monitoring Centre for 
Drugs and Drug Addiction (EMCDDA) (EMCDDA & Eurojust, 2016) or the United Nations on Drugs and Crime (UNODC) 
(UNODC, 2017). However, the rate at which they are emerging causes difficulties for existing reactive systems of drug 
control. A modification of the substance structure can easily be done once the legislation to prohibit this substance is passed 
(Chatwin, Measham, O'Brien, & Sumnall, 2017). In terms of control and policy, there is no uniform legal framework between 
countries to address the problem of new psychoactive substances (King, 2013). Furthermore, the definition of NPS itself raises 
(Corazza, Demetrovics, van den Brink, & Schifano, 2013). 
substances are newly-abused (King, 2013), while others refer to the lack of knowledge about them (Potter & Chatwin, 2018). 
In the last few years, technologies have offered new opportunities to extend and diversify the trade of illicit and licit drugs 
and exchange information. The Web is the main application used on a daily basis by millions of users, and thus the central 
location on which illicit trade has developed. The other applications  such as those designed for messaging or peer-to-peer 





purposes  are also used as a vector to promote illicit trafficking, even though they have not been extensively studied in that 
context so far (Kruithof et al., 2016; Rossy & Décary-Hétu, 2018). Most academic research regarding online illicit trade on 
the Web has focused on the trafficking of both illicit drugs and NPS (Barratt & Aldridge, 2016; EMCDDA, 2016, 2017a; 
Kruithof et al., 2016). The former seems to be mainly accessible on cryptomarkets on Dark Webs1 (using protocols such as 
TOR or I2P), while the latter appears to be more visible on the Web, since they are not necessarily illegal  or at least not yet 
in many countries  according to the major conventions on narcotic drugs (i.e. Single Convention on Narcotic Drugs of 1961, 
and Convention on Psychotropic Substances of 1971). 
The Psychonaut 2002 project and its subsequent developments such as the ReDNet project (Corazza, Assi, et al., 2013; 
Psychonaut Web Mapping Research Group, 2005) aimed to gather information from online sources to improve the knowledge 
of the phenomenon. In the first project, they highlighted a range of online resources related to NPS (i.e. forums, blogs, 
information website and online shops). Then, discussion forums were studied in more details, by reading their content and 
monitoring new posts regularly. This task was described as time-consuming, though very informative since the content of the 
forum was deemed exclusive and relevant. At the time of the study, no other sources of information provided such an 
Psychonaut Web Mapping project 
produced technical reports about 31 substances, fuelled by literature review and information gathered online (in particular, 
chemical and physical characteristics, price, route of administration, legal status, misuse, combinations and effects) 
(Psychonaut Web Mapping Research Group, 2010). 
Other studies have focused on the analysis of web shops offering NPS. According to the EMCDDA-Europol (2016) 651 web 
shops were identified on the Web in 2013 (EMCDDA & Europol, 2016). More recently, the iTrend project offered a 
multidisciplinary approach to conduct test purchases of different substances through the Web. Some NPS offered for sales 
turned out to be different from what was advertised, with also important variations in purity (Brunt et al., 2017; EMCDDA, 
2016). The websites on which these substances were sold were studied, revealing specific strategies (e.g. free samples,
testimonials or efforts to suggest the website authenticity) used by the vendors to market their substances (Meyers et al., 
2015). Monitoring such websites over time indicated that the market has changed, with new substances emerging regularly. 
For example, a monitoring process applied to a selection of 43 web shops over twelve months highlighted ten new products 
per month (Bruno, Poesiat, & Matthews, 2013). 
Apart from hosting web shops, the Web is also a source of information for both potential drug consumers and experienced 
users. In the context of NPS, discussion forums are a meeting point for these groups of users and include a wide range of 
questions, answers and consumption tips. The potential of discussion forums to provide insights into the appearance of novel 
substances on the market was highlighted in the literature (Sedefov, Gallegos, Mounteney, & Kenny, 2013). Several 
qualitative and quantitative studies focused on the content of discussion forums. For example, the history of the first generation 
s 
of a Norwegian forum (Bilgrei, 2016). From a Swedish perspective, trip reports posted on the Flashback forum about synthetic 
cannabinoids revealed the intoxicating power of these products, as well as both positive and negative effects (Kjellgren, 
Henningsson, & Soussan, 2013). The addition of eight compounds to the Swedish list of controlled substances impacted on 
the daily number of messages posted on this forum (Ledberg, 2015). Finally, discussion forums may also be used to spread 
surveys or recruit participants for interviews in order to study NPS use and consumers (Soussan & Kjellgren, 2016). 
Discussion forums are also found on the Dark Web and may be linked to specific cryptomarkets. The forums of four 
cryptomarkets  AlphaBay, Valhalla, Dream market and Nucleus  were qualitatively studied, highlighting specific themes 
of discussion related to particular aspects of NPS (e.g. motives of use, trafficking and reputations of sellers) (Van Hout & 
Hearne, 2017). 
Anticipation is a primary objective in the context of the NPS phenomenon, as shown by the efforts of the UNODC and 
EMCDDA to develop early-warning systems. In parallel, literature reveals that the Web plays a major role in the NPS market, 
since some websites or discussion forums are used to promote, sell and discuss NPS. Even if the market is not entirely 
concentrated online, the Web may constitute another rich source of information that could be used in an early-warning 
perspective. In the context of academic research, drug discussion forums have been qualitatively studied or used as part of 
multiple datasets (Psychonaut Web Mapping Research Group, 2005, 2010). While this type of research is essential to 
understand how such datasets might be used, they are difficult to reproduce and time-consuming since they imply a lot of 
 
 
1 In the context of this research, we distinguished between the Web  maintained and regulated by the major Internet 
organisations  and the Dark Web  self-regulated parts of the Web accessible via specific protocols (e.g. TOR or I2P). A 
 





readings and manual classification.  
This research aims at understanding the contribution of data extracted from an online discussion forum within a systematic 
monitoring process. A systematic approach - combined with the right degree of automatisation - could produce a monitoring 
process based on multiple iterations of the data gathering and analysis steps. The word systematic implies that the data 
collection process gather the content of an entire forum (or a forum section) and structure the data so that all the relevant  
content of the forum can be analysed subsequently. The analysis process and the detection of patterns would thus rely on the 
complete content and provide a more accurate understanding of substances of interest.  
To address this aim, data extracted from the Drugs-forum website were used to study the interest of consumers over time 
about selected substances and compare the results to the literature about these substances. Drugs-forum is hosted on the Web 
and is a major discussion forum covering drugs in general, with an important focus on harm reduction. As such, it informs on 
the practice of consumers and appears to be more appropriate than cryptomarkets forums which would include discussion 
about transactions, dispute between sellers and vendors and other topic specific to cryptomarkets, rather than NPS-related 
exchange of information. This research is a proof of concept and has the potential to bring complementary and new 
information about these new psychoactive substances in terms of use and interest by consumers. Pineau et al. (2016) described 
such a process in their research about doping products. In the context of NPS, monitoring substances through the analysis of 
discussion forums could help identify the most discussed substances among consumers. Such a result could be used as a proxy 
to assess the popularity of substances over time. A process similar to the one described in the present research could not only 
be used in an academic context, but also by organizations involved in the early detection and monitoring of the NPS 
phenomenon. It could help target efforts (i.e. law enforcement as well as prevention) on specific problematic substances and 
help policy mak
strength the already in place early-warning systems. 
2. Dataset and methodology 
2.1. Data collection 
Drugs-forum opened in 2003 and now includes more than 250,000 registered members and a wide range of discussions (i.e. 
more than 220,000 discussion threads). This forum was chosen because of its size. Indeed, it may be considered as a public 
space since hundreds of thousands of people are present on it. Moreover, the terms of use of the forum (https://drugs-
forum.com/wiki/Terms_of_Use) defined the content of the sections as publicly posted. No personal data such as pseudonym 
or specific verbatim were used in the research. In line with previous research on drug forum (Van Hout & Hearn, 2017) and 
for ethical and privacy reasons (i.e. to avoid putting individuals at risk of prosecution and/or disrupting a safe space for 
stigmatised individuals), all results presented are aggregated and cannot be linked to any virtual identity. 
Python-coded system was designed to crawl the Drugs-Forum website and scrape the data (versions: Python 2.7 and its library 
ts 
respective following pages. All these pages are then browsed, data related to each discussion thread is duplicated (restructured 
if necessary) and stored into a dedicated database. Data related to 84,678 discussion threads was collected. In particular, the 
title of each thread was extracted, as well as its date of creation, and the number of views and replies it generated. The number 
of users who took part in the discussions was also recorded. Further analysis was conducted using the Tableau Desktop 10.5 
visualisation software. 
2.2. Targeted substances 
The United Nations Office on Drugs and Crime (UNODC) categorises NPS in nine classes namely phenethylamines, synthetic 
cannabinoids, synthetic cathinones, piperazines, tryptamines, aminoindanes, phencyclidine-type substances, plant-based 
substances, and other substances (https://www.unodc.org/LSS/SubstanceGroup/GroupsDashboard?testType=NPS). A 
selection of the most common NPS reported to the UNODC Early Warning Advisory on NPS was made to cover each class 
complete name of each substance is detailed in Table 3, in the Appendix.   
It is important to mention that some substances in Table 1 might not be considered as NPS anymore in certain countries due 
to legislative changes (e.g. khat, MXE). Although it may be seen as a limitation, a deeper knowledge about these substances 
is likely to be available in the literature since they have been known for at least a few years. In the context of a proof of  
concept, previous research about these substances would provide information that could be compared to our findings. They 
were thus considered in this study as they might help assess the contribution of discussion forums analysis for early-warning 






Table 1. Targeted substances
Class Substance Class Substance 
1/ Phenethylamines PMMA 4/ Piperazines BZP 
  25c-NBOMe   MBZP 
  25i-NBOMe   mCPP 
  2C-E   MT-45 
  2C-T-2   PFPP 
  4-FA   TFMPP 
  5-APB 5/ Tryptamines AMT 
  6-APB   4-AcO-DipT 
  2-CB-FLY   4-AcO-DMT 
2/ Synthetic 
cannabinoids 
HU-210   5-MeO-DMT 
  JWH-018   5-MeO-DPT 
  JWH-073 6/ Aminoindanes MDAI 
  JWH-250   NM-2AI 
  AM-2233   2-AI 
  APINACA   5-IAI 
  AB-PINACA 7/ PCP-type substances MXE 
3/ Synthetic cathinones a-PVP   4-MEO-PCP 
  MDPV   3-MEO-PCP 
  Mephedrone 8/ Plant-based 
substances 
Khat 
  n-ethyl-pentylone   Kratom 
  3-FMC   Salvia divinorum 
    
 
A specific analysis was carried out on 15 substances (see Table 2) that were the subject of risk assessments by the EMCDDA 
between 1999 and 2017 (EMCDDA, 2010; Sedefov et al., 2013).   
Table 2. Targeted substances that were the subject of an EMCDDA Risk  
Class Substance Date of report 
1/ Phenethylamines 25i-NBOMe 2014 
-DMAR 2014 
5-IT 2013 
2/ Synthetic cannabinoids ADB-CHMINACA 2017
CUMYL-4CN-BINACA 2017
  AB-CHMINACA 2017 
5F-MDMB-PINACA 2017
MDMB-CHMICA 2016
3/ Synthetic cathinones a-PVP 2015 
  MDPV 2014 
  Mephedrone 2010 
4/ Piperazines BZP 2007 
 mCPP 2005 
 MT-45 2014 
7/ PCP-type substances MXE 2014 





2.3. Choice of indicator
The indicators available to assess the popularity of a substance were the number of views, the number of replies, the number 
of distinct authors involved in a discussion thread, and the number of threads related to this substance (Pineau et al., 2016). 
Regular expressions were used to search for the name of substances in the titles while taking into account the variations of a 
substance name (e.g. JWH-
coefficients was calculated between each of the indicators, for every substance in Table 1. Each calculated correlation was 
above 0.93 (p-value < 0.001). Thus, any indicator may be chosen to assess the popularity of a substance. Knowledge about 
the way the forum works may complement such correlation and help selecting an indicator. For instance, Pineau et al. (2016), 
discussion threads. Flooding is indeed a common practice on forums about doping products, where vendors may advertise for 
replies across all threads related to a substance was selected to assess its popularity. It is worth noting that the indicator used 
in the present research is a reflection of the intensity of the discussions related to a substance. This measure of intensity is 
used as a proxy to estimate the popularity of a substance among the users of an online forum. This estimation of popularity 
has limitations and will be discussed in more detail in section 4. In particular, the negative side effects of a substance may 
fuel discussion (e.g. 'reverse popularity'). Alternatively, the substance may still be popular but the intensity of discussions 
may decrease or cease entirely because existing threads may have covered every topic and question related to that substance. 
In such cases, the substance could still be popular but its popularity not being reflected in discussion intensity.  
The 
views is not necessarily related to the activity of the population of interest (i.e. consumer). Its incrementation depends on how 
the website is working (i.e. different ways of counting multiple connections with a same IP address). The number of threads 
-
sometimes used to gather as much information as possible, while some precise questions or trip reports are the subject of 
specific threads. The same applies to the number of distinct first authors, since some forum users  moderators for instance  
may start discussions more often than other users. Thus, the number of replies was chosen as an indicator for each substance. 
2.4. Analysis 
First, the timeframe during which a substance was present (i.e. discussed) on the discussion forum was calculated and 
represented over time. Secondly, the changes in popularity of this substance over time were studied in more details. Two 
conditions were required to consider a substance as being present on Drugs-forum during a given month. First, threads related 
to the substance should have replies over the month. Second, the monthly number of replies related to this substance 
represented at least 1% of the total number of replies across the threads related to this substance. The timeframe during which 
a substance was present on the forum was then visualised. This timeframe starts with the creation date of the first thread 
discussing the substance. It ends with the creation date of the last thread that generated at least 1% of the replies, without 
considering any interruption. 
Changes in popularity for each substance was investigated over the timeframe. As performed by Pineau et al. (2016) in the 
context of doping products, the number of replies was normalised and represented over time. Different patterns were then 
highlighted visually (i.e. chronic, downward, upward), as well as particular peaks of interest. 
When a substance was the subject of an EMCDDA risk assessment, the first official notification of the substance through the 
early warning system was systematically mentioned in the risk assessment report. For the 15 selected substances, this date 
was compared to the appearance of the substances on the forum. 
 
3. Results and discussion 
3.1. Presence of the forty-two NPS on the forum 
Figure 1 summarises the length of discussion of the forty-two substances selected on the Drugs-forum over the 2003-2018 
period.





Figure 1. Presence of each substance on the forum (at least 1% of the total number of replies across the threads 
related to a substance).
 
 





It is interesting to note an evolution of the different classes of substance as well as the evolution of particular substances within 
a same class. Some substances have been discussed over a long period of time (e.g. kratom, salvia divinorum, AMT) while 
others were discussed very briefly (e.g. 5-MeO-DPT, NM-2AI, AM-2233). For example, plant-based substances have been 
traditionally consumed for a long time in specific regions (e.g. khat was originally consumed in Eastern Africa, kratom in 
South East Asia and Salvia divinorum in Central America) before being classified as NPS (Feng, Battulga, Han, Chung, & 
Li, 2017; Gibbons & Arunotayanun, 2013), while synthetic compounds were manufactured more recently (e.g. NM-2AI). In 
contrast, a succession in the appearance of synthetic cannabinoids and synthetic cathinones is observed. A similar trend was 
reported in the literature where different generations of these classes subsequently appeared on the market (Watterson & 
Foster Olive, 2014; Wilson-Hohler, Fathy, & Mozayani, 2016). The trends drawn by analysing this online discussion forum 
reflect the information from the literature. This tends to confirm that such forums are a valid source to monitor the appearance 
of substances on the market. 
Some substances (e.g. khat, BZP, 2-AI, 5-IAI, 4-AcO-DipT) were discussed on the forum but only sporadically reported in 
the literature or reported in a particular population. For example, the prevalence of aminoindanes was considered as very low 
in 2013 (Brandt, Braithwaite, Evans-Brown, & Kicman, 2013). This could explain why two of them  2-AI and 5-IAI  were 
not discussed after 2013. Similarly, 4-AcO-DipT seems to be particularly anecdotal in terms of seizures and use (Greene, 
2013). Khat is used by very specific migrant populations. Some of them migrated to Europe and America, explaining why 
this kind of substance has spread across the world (Gibbons & Arunotayanun, 2013). Most of the forum discussions related 
to this substance are about cultivation, which is in line with the fact khat does not seem to be offered for sale on the Web 
(EMCDDA, 2015). The legislation regarding plant-based substances is likely to influence the discussion on the forums. It 
took a long time for plant-based substances to be controlled and thus the length of their discussion on the forum might be 
related to that. For example, the commerce of khat is controlled by the UK Psychoactive Substances Act of 2016, while the 
question is still debated in the United States. Similarly, kratom - a plant originally grown in Asia - has been discussed for a 
long time on the forum, probably because it was not controlled in Europe until 2011 and only in a few countries (EMCDDA, 
2015). 
3.2. Substance popularity 
 
Figure 2 shows the evolution of the popularity of each substance over their respective timeframe 
Generally, the popularity of most substances on the forum follows a downward trend. Several hypotheses can be raised to 
explain this observation. It could indicate a loss of interest for the substance, due to a decrease in availability or negative 
health effects reported. Alternatively, the early discussions could have covered a large number of topics, implying that 
potential consumers are able to find answers to their questions without having to write replies or create new threads. Chronic 
trends are also present for certain substances (e.g. MDPV, a-PVP, kratom, 25i-NBOMe). This chronic trend could be related 
to the constant popularity of these substances over the years (EMCDDA, 2015). 
In some cases, temporary spikes of interest for a specific substance were noted. In general, the peak of interest is close to the 
appearance of the substance on the forum. For instance, the peak observed in October 2009 for the synthetic cannabinoid 
JWH-018 is related to discussions about its short-term and long-term effects. Similarly, mephedrone is characterised by a very 
important spike between 2009 and 2010 related to the effects of the substance (>600 replies for threads created during that 
timeframe). Such a result could be due to the actual popularity of the substance at that time. On the other hand, the discussions 
ment which led to 
the international control of mephedrone (Wood & Dargan, 2013). Plant-based substances are also characterised by spikes in 
popularity due to threads about their effects and possible addiction problems. 
Despite the general downward trend, some upward patterns were sometimes noted. For instance, the sudden increase in replies 
regarding 2C-B-FLY in October 2009 was due to three threads related to the potential harm caused by the substance following 
an incident (Power, 2013). Likewise, an increase of interest was noted for mCPP in August 2009. It was caused by a discussion 
about the results of a Dutch testing program reporting the presence of mCPP in tablets or its use as an adulterant of MDMA. 
Given the negative effects of mCPP reported by users (Bossong et al., 2010), MDMA probably supplanted it on the market.





Figure 2. Popularity of each substance over time 
 





3.3. Potential of drug forums 
Figure 3 compares the appearance of fifteen substances on the forum to the date of formal notification to the EU early warning 
system.  
Figure 3. Comparison between the presence on the forum and the date of formal notification to the EU Early 
Warning System (black dot).  
 
 
Out of the fifteen substances, nine of them appeared on the forum before or at the same time as their first date of notification 
to the EU early warning system. Interestingly, all synthetic cannabinoids that were subject to a risk assessment by the 
EMCDDA were only shorty discussed or not discussed at all on the forum. According to the risk assessment of ADB-
CHMINACA, CUMYL-4CN-BINACA, 5F-MDMB-PINACA, MDMB-CHMICA and AB-CHMINACA (EMCDDA, 
2017b, 2018a, 2018b, 2018c, 2018d), these substances are commonly administered by smoking a cigarette of herbal mixture 
laced with the substance. Since the ingredients are rarely stated, most users are not aware that they are consuming such a 
substance and are thus not aware of its name. This could explain why such substances are not discussed on the forum. 
Furthermore, according to the same risk assessment, no widespread use of these substances is reported. In regards to BZP 
which appears quite late in comparison to the first date of notification, its first mention was in 1991 by Alexander Shulgin, 
-DMAR 
on the discussion forum three years before its formal notification to the EU early warning system (EMCDDA, 2014). 
According to the discussion threads, the substance seems to be very difficult to obtain and results in negative sides effects. 
That might explain why this substance was reported at a later stage. 
These results are preliminary; however, they show the potential of online discussion forums to complement early-warning 
systems. 
 
4. General discussion and conclusion 
This research demonstrates the potential of analysing online discussion forums to strengthen existing early-warning systems 
and monitor NPS popularity using an indicator based on data extracted from the forum as a proxy. 
The trends observed by analysing data from online discussion forums reflect the scattered information available in the 
literature. Such a result is in line with the findings of the Psychonaut projects, particularly regarding the exclusiveness of the 
information gathered online (Psychonaut Web Mapping Research Group, 2005, 2010). Conversely, these projects were fuelled 
by qualitative analyses and included some time-consuming steps (e.g. reading, classification). A systematic approach - like 
the one developed in the present research - when periodically implemented could overcome these problems. Indeed, the data 
collection system is designed in a way which allows the complete reiteration of the process regularly. Combined with temporal 
data, it enables a monitoring process allowing to follow the intensity of discussions about particular substances over time.  
More importantly and irrespective of the indicator chosen, the approach offers complementary and useful findings regarding 
the first appearance of a drug on the market. Out of the fifteen substances that were the subject of risk assessments by the 
EMCDDA between 1999 and 2017, nine of them appeared on the forum before or at the same time as their first date of 
notification to the EU early warning system. 
Formally, the concept of popularity is defined by the favour of the general public or of a group. In the context of substance 
consumption, it translates as a large number of consumers. Paradoxically, popularity is sometimes reported in the context of 
psychoactive substances, while it is not strictly defined. For example, a rising popularity may be explained by the increased 





availability or the effects of a substance (Coppola & Mondola, 2012). Since the concept of popularity is difficult to define, 
be an alternative. Choosing such an indicator as a proxy is not without limitations. However, when observed over time, these 
indicators may show variations due to positive (e.g. desired effects, no side effects, availability of the substance) or negative 
discussions (e.g. intoxications, side effects, warnings about substance use). Used within a monitoring system, such an indicator 
would inform on the evolution - or the non-evolution - of discussions about a substance. In order to strengthen early-warning 
systems, alerts could also be defined based on sudden rises or temporary spikes, whether the spike is due to positive or negative 
discussions. The former could inform on the possibility to see this substance more frequently on the market, while the later 
could trigger preventives measures. In any case, such information would benefit law enforcement agencies, health 
organizations and policy makers.   
While other publicly available data sources (EMCDDA, 2016; UNODC, 2017) on NPS often present aggregated data (e.g. by 
class of substance), the proposed approach allows to target specific substances on a longer period of time. It also shows the  
emergence, persistence or transient nature of the substances. This finding is interesting as it could direct the focus of law 
enforcement resources and research towards a limited number of substances rather than all new substances. Harm reduction 
initiatives (e.g. prevention campaigns) could also benefit from this knowledge (e.g. addiction problems discussed on the 
forums) (Corazza, Assi, et al., 2013). Since it will never be possible to anticipate the emergence of all new substances, 
monitoring systems fuelled by data extracted from online sources might strengthen early-warning initiative already 
implemented. 
Although Drugs-forum was the only forum considered for this study, it is a major discussion forum related to drugs. However, 
this process could be fuelled by data gathered from other forums. The data collection process can be adapted to other 
discussion forums, providing a few adaptations due to the fact that all forums are not exactly structured in the same way. This 
could be particularly interesting if adapted to forums focused specifically on one country as problems may be country specific 
(see for example the Swedish and Norwegian forums studied respectively by Ledberg (2015) and Bilgrei (2016). In the future 
and to address these limitations, it could be interesting to combine the results obtained through online monitoring to data from 
the physical market, such as results of drug-testing programs, waste-water analysis and seizures from customs and border 
forces (Morelato et al., 2018). As any source of information, discussion forums have limitations and the authors believe that 
the combination of complementary information would provide policy makers with a more complete picture of the NPS 
phenomenon. 
Finally, in the context of NPS, important differences between classes of substances were noted, in terms of market and interest 
from consumers. Indeed, some classes are discussed, while others are barely present. It suggests that each class  and even 
each substance  has its own specificities. A variety of factors may influence how a substance is going to spread or influence 
the market (Stogner, 2015). Thus, the concept of NPS itself may not be appropriate to describe these substances, as argued by 
Potter and Chatwin (2018). They provide a critical view of NPS as a category. Considering each class individually, rather 
a more accurate way to define them and 
understand the specificity of each class of substances. 
  






Table 3. APPENDIX - Name of the targeted substances 
Class Substance Also known as 
1/ Phenethylamines PMMA 4-methoxy-N-methylamphetamine ; 4-MMA 
25c-NBOMe 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine ; 2C-
C-NBOMe 




























CUMYL-CYBINACA or SGT-78 
 AB-CHMINACA N-(1-amino-3-methyl-1-oxobutan-2-yl)- 1-(cyclohexylmethyl)-1H-
indazole-3-carboxamide 
















n-ethyl-pentylone -keto-ethylbenzodioxolylpentanamine ; k-EBDP 
3-FMC 3-fluoromethcathinone  




PFPP para-fluorophenylpiperazine  
TFMPP 3-trifluoromethylphenylpiperazine  
















Khat Qat, Catha edulis 
Kratom Mitragyna speciosa 
Salvia divinorum - 
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